Already FDA-approved to treat major depression and migraines, TMS can now be marketed as a treatment for obsessive compulsive disorder Santa Barbara, Calif., September 21, 2018 – Transcranial Magnetic Stimulation (TMS) therapy is rapidly growing in popularity as a treatment [..]
Leading National TMS provider—more locations, more doctors, more experience, more success!
Over 2/3 of patients reported a 50% or greater reduction in their symptoms and 45% experienced complete remission of their depression symptoms and sustained these results for 12 months.
Insurance coverage is widely available
Insurance Coverage Information
Patient Self Assessment & Tools
TMS Information for Practitioners
APA Guidelines
TMS Success Stories
NEWS / RESEARCH
